Effect of Borago Officinalis Extract on Moderate Persistent Asthma: A Phase two Randomized, Double Blind, Placebo-Controlled Clinical Trial
Randomized trial
Abstract
In a phase-two randomized, double-blind, placebo-controlled trial, Borago officinalis extract improved moderate persistent asthma, an effect linked to its suppression of TNF-alpha and its gamma-linolenic-acid content, supporting its anti-inflammatory respiratory use.
Referenced for these plants
How to cite
Mirsadraee, M., Khashkhashi Moghaddam, S., Saeedi, P. and Ghaffari, S (2016) 'Effect of Borago Officinalis Extract on Moderate Persistent Asthma: A Phase two Randomized, Double Blind, Placebo-Controlled Clinical Trial', Tanaffos, 15(3), pp. 168-174.
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.